Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Boeing
BA
|
$1.54B |
| 2 |
D.R. Horton
DHI
|
$1.12B |
| 3 |
NVIDIA
NVDA
|
$967M |
| 4 |
Netflix
NFLX
|
$943M |
| 5 |
GE Aerospace
GE
|
$924M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.58B |
| 2 |
Apple
AAPL
|
$1.54B |
| 3 |
Amazon
AMZN
|
$1.47B |
| 4 |
Alphabet (Google) Class C
GOOG
|
$1.43B |
| 5 |
Microsoft
MSFT
|
$1.22B |
Sector Composition
| 1 | Technology | 18.98% |
| 2 | Healthcare | 17.33% |
| 3 | Industrials | 12.85% |
| 4 | Consumer Discretionary | 11.86% |
| 5 | Financials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Beam Therapeutics
BEAM
$1.66B
| $8.9M | ﹤0.01% | +227,566 | New | +$8.9M |
|
402
Playtika
PLTK
$1.39B
| $8.58M | ﹤0.01% | 1,008,409 -1,295,257 | -56% | -$11M |
|
|
JOAN
403
DELISTED
JOANN, Inc. Common Stock
JOAN
| $7.78M | ﹤0.01% | 2,729,250 | – | – |
|
|
PETQ
404
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $7.26M | ﹤0.01% | 787,484 -93,077 | -11% | -$858K |
|
405
Semtech
SMTC
$5.04B
| $6.93M | ﹤0.01% | 241,587 -433,413 | -64% | -$12.4M |
|
406
BARK
BARK
$153M
| $6.71M | ﹤0.01% | 4,500,000 +2,000,000 | +80% | +$2.98M |
|
407
Health Catalyst
HCAT
$239M
| $6.05M | ﹤0.01% | 568,785 | – | – |
|
408
Procore
PCOR
$10.4B
| $5.93M | ﹤0.01% | 125,600 | – | – |
|
409
LivePerson
LPSN
$90.1M
| $4.72M | ﹤0.01% | 465,104 -385,000 | -45% | -$3.9M |
|
410
XP
XP
$9.56B
| $4.48M | ﹤0.01% | 292,000 | – | – |
|
411
CEVA Inc
CEVA
$531M
| $4.48M | ﹤0.01% | 175,000 | – | – |
|
412
Ryanair
RYAAY
$33.7B
| $4.4M | ﹤0.01% | 58,886 -595,222 | -91% | -$44.5M |
|
413
UiPath
PATH
$5.95B
| $4.13M | ﹤0.01% | +325,000 | New | +$4.13M |
|
414
Strategy Inc Common Stock Class A
MSTR
$94.8B
| $4.11M | ﹤0.01% | 29,004 -27,124 | -48% | -$3.84M |
|
415
JFrog
FROG
$5.76B
| $3.81M | ﹤0.01% | 178,400 | – | – |
|
416
Sony
SONY
$165B
| $3.49M | ﹤0.01% | 45,568 -2,626 | -5% | -$201K |
|
417
TSMC
TSM
$1.2T
| $3.35M | ﹤0.01% | 44,115 +6,122 | +16% | +$465K |
|
418
Ares Management
ARES
$39.3B
| $3.13M | ﹤0.01% | 45,670 | – | – |
|
419
ASML
ASML
$292B
| $3.02M | ﹤0.01% | 5,468 -377 | -6% | -$208K |
|
420
Novo Nordisk
NVO
$251B
| $2.99M | ﹤0.01% | +22,126 | New | +$2.99M |
|
421
Schrodinger
SDGR
$1.44B
| $2.89M | ﹤0.01% | 154,790 +123,540 | +395% | +$2.31M |
|
422
Rapid7
RPD
$1.34B
| $2.42M | ﹤0.01% | 71,250 | – | – |
|
423
Woodside Energy
WDS
$32.6B
| $2.07M | ﹤0.01% | 86,464 -4,172 | -5% | -$99.8K |
|
424
Organon & Co
OGN
$2.45B
| $1.99M | ﹤0.01% | 71,425 | – | – |
|
425
SPDR S&P 500 ETF Trust
SPY
$658B
| $1.84M | ﹤0.01% | 4,787 +2,424 | +103% | +$929K |
|